Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

MEDICAMEN BIOTECH LTD.

NSE : MEDICAMEQBSE : 531146ISIN CODE : INE646B01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE491.70-3.15 (-0.64 %)
PREV CLOSE () 494.85
OPEN PRICE () 495.00
BID PRICE (QTY) 491.60 (7)
OFFER PRICE (QTY) 493.75 (7)
VOLUME 393
TODAY'S LOW / HIGH ()490.00 498.45
52 WK LOW / HIGH ()356.75 903.5
NSE493.05-1.4 (-0.28 %)
PREV CLOSE() 494.45
OPEN PRICE () 491.90
BID PRICE (QTY) 493.00 (23)
OFFER PRICE (QTY) 493.75 (46)
VOLUME 1761
TODAY'S LOW / HIGH() 491.90 501.30
52 WK LOW / HIGH ()355.45 845
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1993

Management Info :

Rahul Bishnoi - Chairman - Managing Director

Registered Office :

Address : 1506,Chiranjiv Tower,43, Nehru Place,
New Delhi,
Delhi-110019

Phone : 011-47589500-51

Website : www.medicamen.com

Registrar's Details : Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE
NEWS
23Mar Medicamen Biotech informs about disclo
Medicamen Biotech has informed that it enclosed disclosure under regulat..
23Mar Medicamen Biotech informs about disclo
Medicamen Biotech has enclosed the disclosure under Regulation 29(2) of..
16Mar Medicamen Biotech informs about disclo
Medicamen Biotech has attached disclosure dated March 16, 2024 in Form-D..
08Mar Medicamen Biotech informs about disclo
Medicamen Biotech has informed that it attached disclosure dated March 0..
03Oct Medicamen Biotech informs about closur
In terms of the provisions of the Code of Conduct to Regulate, Monitor a..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit27.66150.01
Gross Profit 40.09 173.32
Operating Profit 64.15266.09
Net Sales 442.041378.84
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
NGL Fine-Chem (BSE)
 2396.00 (2.62%)
M.Cap ( in Cr)
1488.38
Shree Ganesh Remed. (BSE)
 609.85 (7.89%)
M.Cap ( in Cr)
786.89
RPG Life Sciences (BSE)
 1497.80 (2.95%)
M.Cap ( in Cr)
2482.42
Lincoln Pharma (BSE)
 627.70 (4.94%)
M.Cap ( in Cr)
1250.46
Torrent Pharma (BSE)
 2679.95 (1.11%)
M.Cap ( in Cr)
90515.54
Shareholding Pattern
NON-INSTITUTION 55.69%
PROMOTERS 43.21%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
Motilal Oswal S&P B...0.02
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX72741.02-246.01 (-0.34%)
NIFTY22140.75-59.80 (-0.27%)
Dow Jones 39908.00349.89 (0.88%)
Nasdaq 16742.39231.21 (1.40%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI